Oncotelic Therapeutics, Inc. OTLC
0.02 USD 0.00 0.00%
As of Nov 2, 3:51 PM ET
- YTD
- -79.38%
- 1 year
- -83.50%
- Open
- 0.0195
- Prev close
- 0.0165
- Mkt cap
- 7.55M
- Vol
- 325.95K
- Avg vol
- 337.13K
- EPS
- 0.59
- P/E
- 0.03
More statistics
- Low
- 0.016
- High
- 0.0195
- Earnings
- Aug 18, 2023
MAX chart
Chart tools
Chart is warming up
The all-time price history for OTLC has not been loaded yet. Try again in a moment.
Altman Z-Score
3.74 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A+4 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 4
- P/B 5
P/E 0.1×
P/S 0.0×
P/B 0.1×
P/FCF -23.9×
EV/EBITDA 0.1×
EV/Sales 0.0×
FCF Yield -4.2%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 94.9%
ROIC -0.6%
ROA 63.4%
Revenue 0.0%
Operating Income 99.9%
EPS (diluted) 5367.9%
Free Cash Flow -86.8%
Current Ratio 0.1×
Quick Ratio 0.1×
Debt / Equity 0.1×
Net Debt / EBITDA 0.0×
Interest Coverage -3.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31